Literature DB >> 22795338

Hyperinsulinemia and insulin resistance is associated with low T₃/T₄ ratio in pre diabetic euthyroid Pakistani subjects.

Tasnim Farasat1, Abdul Majeed Cheema, Muhammad Naeem Khan.   

Abstract

OBJECTIVE: To investigate the relationship of thyroid hormones in glucose homeostasis in impaired glucose-tolerant subjects with normal thyroid functions.
METHODS: Cross-sectional analysis was carried out in (n=260) impaired glucose-tolerant (IGT) and normal glucose-tolerant (NGT) subjects. Thyrotropin (TSH), total triiodothyronine (TT₃), total thyroxin (TT₄) free T₃ (fT₃), free T₄ (fT₄), and insulin were assessed by enzyme-linked immunoassays (ELISA). Fasting plasma glucose (FPG) and HbA1c were measured by glucose oxidase and low-pressure cation exchange chromatography. Homeostasis model of assessment (HOMA-IR) was employed to assess the level of insulin resistance; fT₃/fT₄ ratio was calculated. Anthropometric measurement and habits were recorded.
RESULTS: Marked hyperinsulinemia and insulin resistance were observed in IGT subjects. Serum TT₃ and fT₃ levels were significantly low in the IGT as compared to normal glucose-tolerant (NGT) controls. TT₄ and TSH were higher in IGT subjects as compared to control subjects. There was a significant positive correlation of TSH with BMI only in the control group (r=0.351; P<0.05). Correlation of insulin with TT₃, fT₃,and TSH was significant (P<0.05) in IGT subjects. A significant low fT₃/fT₄ ratio was observed in IGT subjects as compared to NGT subjects (P<0.01). In multiple regression analysis, TSH, TT₄ and fT₃ contributed significantly to the variance of fasting insulin and insulin resistance in IGT subjects.
CONCLUSION: Hyperinsulinemia and insulin resistance are associated with low T₃/T₄ ratio in pre-diabetic euthyroid Pakistani subjects.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795338     DOI: 10.1016/j.jdiacomp.2012.05.017

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Endocrine       Date:  2018-04-12       Impact factor: 3.633

2.  Effects of glucose, insulin and triiodothyroxine on leptin and leptin receptor expression and the effects of leptin on activities of enzymes related to glucose metabolism in grass carp (Ctenopharyngodon idella) hepatocytes.

Authors:  Rong-Hua Lu; Yi Zhou; Xiao-Chen Yuan; Xu-Fang Liang; Liu Fang; Xiao-Li Bai; Min Wang; Yu-Hua Zhao
Journal:  Fish Physiol Biochem       Date:  2015-05-08       Impact factor: 2.794

3.  Clinical Associations of Thyroid Hormone Levels with the Risk of Atherosclerosis in Euthyroid Type 2 Diabetic Patients in Central China.

Authors:  Limin Wang; Tingting Chen; Jiawei Yu; Huijuan Yuan; Xinru Deng; Zhigang Zhao
Journal:  Int J Endocrinol       Date:  2020-07-03       Impact factor: 3.257

4.  Association of obesity-mediated insulin resistance and hypothalamic volumes: possible sex differences.

Authors:  Jenny Ha; Jessica I Cohen; Aziz Tirsi; Antonio Convit
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

5.  Association of Thyroid-Stimulating Hormone and Thyroid Hormones with Cardiometabolic Risk Factors in Euthyroid Children and Adolescents Aged 10-18 Years: A Population-Based Study.

Authors:  Cheol Gyu Ma; Young Suk Shim
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

6.  Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study.

Authors:  Deshan Yuan; Sida Jia; Pei Zhu; Ce Zhang; Yue Liu; Ru Liu; Jingjing Xu; Xiaofang Tang; Xueyan Zhao; Runlin Gao; Yuejin Yang; Bo Xu; Zhan Gao; Jinqing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.